Drug Type Small molecule drug |
Synonyms (±)-secobarbital, 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione + [13] |
Target |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CA (01 Jan 1939) |
Regulation- |
Molecular FormulaC12H18N2NaO3 |
InChIKeyAPVPNHUAMOGOKN-UHFFFAOYSA-N |
CAS Registry309-43-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01310 | Secobarbital Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | JP | 29 Sep 1961 | |
Sedation | JP | 29 Sep 1961 | |
Sleep Initiation and Maintenance Disorders | US | 19 Jul 1950 |